{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:53:06Z","timestamp":1789239186842,"version":"build-2803163510"},"reference-count":111,"publisher":"Elsevier","isbn-type":[{"value":"9780443345296","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.ircmb.2024.08.003","type":"book-chapter","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T12:40:56Z","timestamp":1726231256000},"page":"199-222","source":"Crossref","is-referenced-by-count":2,"title":["Interleukin 10: Bridging the chasms in the immune landscape of multiple myeloma"],"prefix":"10.1016","author":[{"given":"Queenie","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul W.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karama","family":"Makni-Maalej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maysaloun","family":"Merhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Dermime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.003_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ncrna.2023.12.002","article-title":"Role of circular RNAs and gut microbiome in gastrointestinal cancers and therapeutic targets","volume":"9","author":"Abdullah","year":"2024","journal-title":"Noncoding RNA Research"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.003_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ncrna.2023.05.005","article-title":"Circular SERPINA3 and its target microRNA-944 as potential biomarkers in hepatitis C virus-induced hepatocellular carcinoma in Egyptian population","volume":"8","author":"Aborehab","year":"2023","journal-title":"Noncoding RNA Research"},{"issue":"8","key":"10.1016\/bs.ircmb.2024.08.003_bib3","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired","volume":"114","author":"Ahmadzadeh","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.003_bib4","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s12253-015-9921-z","article-title":"Interleukin-10 induces both plasma cell proliferation and angiogenesis in multiple myeloma","volume":"21","author":"Alexandrakis","year":"2015","journal-title":"Pathol. Oncol. Res."},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.003_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1016\/bs.ircmb.2024.08.003_bib6","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bjc.2017.356","article-title":"TAMeless traitors: Macrophages in cancer progression and metastasis","volume":"117","author":"Aras","year":"2017","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.003_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bjh.19227","article-title":"Bridging treatment prior to chimeric antigen receptor T-cell therapy in multiple myeloma","volume":"204","author":"Bal","year":"2024","journal-title":"British Journal of Haematology"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.003_bib8","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1172\/JCI114392","article-title":"Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias","volume":"84","author":"Bataille","year":"1989","journal-title":"Journal of Clinical Investigation"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.08.003_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073587","article-title":"Immunological prognostic factors in multiple myeloma","volume":"22","author":"Bebnowska","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"10.1016\/bs.ircmb.2024.08.003_bib10","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1158\/1541-7786.MCR-19-0487","article-title":"Proinflammatory macrophages promote multiple myeloma resistance to bortezomib therapy","volume":"17","author":"Beyar-Katz","year":"2019","journal-title":"Molecular Cancer Research"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib11","doi-asserted-by":"crossref","first-page":"1161067","DOI":"10.3389\/fimmu.2023.1161067","article-title":"The multifaceted nature of IL-10: Regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions","volume":"14","author":"Carlini","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.ircmb.2024.08.003_bib12","article-title":"Minimal residual disease assessment in multiple myeloma patients: Minimal disease with maximal implications","volume":"11","author":"Charalampous","year":"2021","journal-title":"Frontiers in\u00a0Oncology"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.003_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2019.04.007","article-title":"Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma","volume":"71","author":"Chen","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.003_bib14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1600-0609.2012.01828.x","article-title":"Pre-existing diabetes mellitus in patients with multiple myeloma","volume":"89","author":"Chou","year":"2012","journal-title":"European Journal\u00a0of\u00a0Haematology"},{"issue":"6917","key":"10.1016\/bs.ircmb.2024.08.003_bib15","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.003_bib16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: A review","volume":"327","author":"Cowan","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.003_bib17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s11899-017-0397-7","article-title":"Novel immunotherapies for multiple myeloma","volume":"12","author":"D\u2019Agostino","year":"2017","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.003_bib18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.174.4.915","article-title":"Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"Journal of Experimental Medicine"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.003_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12030424","article-title":"Coinfection of HPVs is associated with advanced stage in colorectal cancer patients from Qatar","volume":"12","author":"Fernandes","year":"2023","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.003_bib20","doi-asserted-by":"crossref","first-page":"2220626","DOI":"10.1080\/21645515.2023.2220626","article-title":"Incidence and association of high-risk HPVs and EBV in patients with advanced stages of colorectal cancer from Qatar","volume":"19","author":"Fernandes","year":"2023","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.003_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9040300","article-title":"Human papillomaviruses and epstein-barr virus interactions in colorectal cancer: A brief review","volume":"9","author":"Fernandes","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122390","article-title":"Chronic inflammation and cancer; The two sides of a coin","volume":"338","author":"Fernandes","year":"2024","journal-title":"Life Sciences"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fonc.2018.00257","article-title":"Role of Epstein-Barr virus in the pathogenesis of head and neck cancers and its potential as an immunotherapeutic target","volume":"8","author":"Fernandes","year":"2018","journal-title":"Frontiers in Oncology"},{"issue":"180","key":"10.1016\/bs.ircmb.2024.08.003_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.24976\/Discov.Med.202436180.1","article-title":"Beyond viral infections: The multifaceted roles of human papillomavirus and Epstein-Barr virus in shaping the tumor microenvironment","volume":"36","author":"Fernandes","year":"2024","journal-title":"Discovery Medicine"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106586","article-title":"Shrinking the battlefield in cancer therapy: Nanotechnology against cancer stem cells","volume":"191","author":"Fernandes","year":"2023","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.003_bib26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4049\/jimmunol.155.3.1079","article-title":"IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes","volume":"155","author":"Finbloom","year":"1995","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.003_bib27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/hematology.2023000434","article-title":"Current use of CAR T cells to treat multiple myeloma","volume":"2023","author":"Firestone","year":"2023","journal-title":"Hematology: The\u00a0American Society\u00a0of\u00a0Hematology Education Program"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.003_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.V97.2.483","article-title":"Autocrine interleukin-6 production and highly malignant multiple myeloma: Relation with resistance to drug-induced apoptosis","volume":"97","author":"Frassanito","year":"2001","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fmed.2017.00092","article-title":"Multiple myeloma cells express key immunoregulatory cytokines and modulate the monocyte migratory response","volume":"4","author":"Freire-de-Lima","year":"2017","journal-title":"Frontiers in Medicine (Lausanne)"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.003_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020217","article-title":"The role of tumor microenvironment in multiple myeloma development and progression","volume":"13","author":"Garcia-Ortiz","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.003_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1139\/cjpp-2023-0202","article-title":"Stem cell therapy for cardiac regeneration: Past, present, and future","volume":"102","author":"Gill","year":"2024","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.08.003_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41408-022-00757-8","article-title":"Second- and third-line treatment strategies in multiple myeloma: A referral-center experience","volume":"12","author":"Goldman-Mazur","year":"2022","journal-title":"Blood Cancer Journal"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.003_bib33","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI73639","article-title":"PD-1 identifies the patient-specific CD8(+) tumor-reactive repertoire infiltrating human tumors","volume":"124","author":"Gros","year":"2014","journal-title":"Journal of Clinical Investigation"},{"issue":"14","key":"10.1016\/bs.ircmb.2024.08.003_bib34","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood-2016-10-745059","article-title":"Bone marrow microenvironment-derived signals induce Mcl-1 dependence in multiple myeloma","volume":"129","author":"Gupta","year":"2017","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cca.2019.12.026","article-title":"Emerging biomarkers in multiple myeloma: A review","volume":"503","author":"Gupta","year":"2020","journal-title":"Clinica Chimica Acta"},{"issue":"8","key":"10.1016\/bs.ircmb.2024.08.003_bib36","first-page":"1133","article-title":"Immunosuppressive effects of multiple myeloma are overcome by PD-L1 blockade","volume":"17","author":"Hallett","year":"2011","journal-title":"Biology of\u00a0Blood\u00a0and\u00a0Marrow\u00a0Transplantation"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.003_bib37","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ncrna.2024.01.009","article-title":"Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism","volume":"9","author":"Hashem","year":"2024","journal-title":"Non-coding RNA\u00a0Research"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.08.003_bib38","first-page":"430","article-title":"Current frontline treatment of multiple myeloma","volume":"36","author":"Holstein","year":"2022","journal-title":"Oncology (Williston Park)"},{"issue":"9","key":"10.1016\/bs.ircmb.2024.08.003_bib39","first-page":"1403","article-title":"Advances in the pathogenesis of multiple myeloma bone disease","volume":"48","author":"Hu","year":"2023","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","article-title":"From monocytes to M1\/M2 macrophages: Phenotypical vs. functional differentiation","volume":"5","author":"Italiani","year":"2014","journal-title":"Frontiers in Immunology"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.003_bib41","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death\u00a0and\u00a0Disease"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.003_bib42","first-page":"282","article-title":"Tumor-infiltrating PD1-positive lymphocytes and FoxP3-positive regulatory T cells predict distant metastatic relapse and survival of clear cell renal cell carcinoma","volume":"6","author":"Kang","year":"2013","journal-title":"Translational\u00a0Oncology"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.003_bib43","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hon.2322","article-title":"Polymorphism of IL-10 receptor beta affects the prognosis of multiple myeloma patients treated with thalidomide and\/or bortezomib","volume":"35","author":"Kasamatsu","year":"2017","journal-title":"Hematol. Oncol"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.003_bib44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/ejh.12577","article-title":"Polymorphisms of IL-10 affect the severity and prognosis of myelodysplastic syndrome","volume":"96","author":"Kasamatsu","year":"2016","journal-title":"European Journal\u00a0of\u00a0Haematology"},{"issue":"9","key":"10.1016\/bs.ircmb.2024.08.003_bib45","first-page":"806","article-title":"Multiple myeloma and the immune microenvironment","volume":"17","author":"Kawano","year":"2017","journal-title":"Current Cancer Drug Targets"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib46","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annual Review of Immunology"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.003_bib47","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2141.2012.09154.x","article-title":"Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells","volume":"158","author":"Kim","year":"2012","journal-title":"British Journal of Haematology"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.08.003_bib48","first-page":"912","article-title":"Interleukin-6 leads to interleukin-10 production in several human multiple myeloma cell lines. Does interleukin-10 enhance the proliferation of these cells?","volume":"34","author":"Kovacs","year":"2010","journal-title":"Leukemia\u00a0Research"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.003_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.17554\/j.issn.2409-3548.2015.01.23","article-title":"Additive\/synergistic effects of interleukin-6 and interleukin-10 on the proliferation of human myeloma cells","volume":"1","author":"Kovacs-Benke","year":"2015","journal-title":"International Journal of Hematology Research"},{"issue":"41","key":"10.1016\/bs.ircmb.2024.08.003_bib50","doi-asserted-by":"crossref","first-page":"62111","DOI":"10.1007\/s11356-021-16726-w","article-title":"Unboxing the molecular modalities of mutagens in cancer","volume":"29","author":"Kumari","year":"2022","journal-title":"Environmental Science and Pollution Research International"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.003_bib51","first-page":"190","article-title":"Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor beta on cancer cells","volume":"44","author":"Kwasniak","year":"2019","journal-title":"Central\u00a0European Journal\u00a0of\u00a0Immunology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.003_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0025-6196(25)00115-6","article-title":"Multiple myeloma: Review of 869 cases","volume":"50","author":"Kyle","year":"1975","journal-title":"Mayo Clinic Proceedings"},{"issue":"18","key":"10.1016\/bs.ircmb.2024.08.003_bib53","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"23","key":"10.1016\/bs.ircmb.2024.08.003_bib54","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1158\/0008-5472.CAN-17-0740","article-title":"IL10 release upon PD-1 blockade sustains immunosuppression in ovarian cancer","volume":"77","author":"Lamichhane","year":"2017","journal-title":"Cancer Research"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.003_bib55","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","article-title":"Distinct role of macrophages in different tumor microenvironments","volume":"66","author":"Lewis","year":"2006","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.003_bib56","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1186\/s12879-020-05412-w","article-title":"Assessment of infection in newly diagnosed multiple myeloma patients: Risk factors and main characteristics","volume":"20","author":"Lin","year":"2020","journal-title":"BMC Infectious Diseases"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.003_bib57","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/tcmj.tcmj_141_20","article-title":"The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma","volume":"33","author":"Liu","year":"2021","journal-title":"Tzu Chi Medical Journal"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.003_bib58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2006-10-051482","article-title":"Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-gamma and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway","volume":"110","author":"Liu","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.003_bib59","first-page":"99","article-title":"Immune checkpoint inhibitors for multiple myeloma immunotherapy","volume":"12","author":"Liu","year":"2023","journal-title":"Experimental Hematology\u00a0&\u00a0Oncology"},{"issue":"18","key":"10.1016\/bs.ircmb.2024.08.003_bib60","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1158\/1078-0432.CCR-11-2939","article-title":"Molecular pathways: Tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment","volume":"18","author":"Lu","year":"2012","journal-title":"Clinical Cancer Research"},{"issue":"14","key":"10.1016\/bs.ircmb.2024.08.003_bib61","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1093\/nar\/20.14.3795","article-title":"A new mouse embryonic stem cell line with good germ line contribution and gene targeting frequency","volume":"20","author":"Magin","year":"1992","journal-title":"Nucleic Acids Research"},{"issue":"9","key":"10.1016\/bs.ircmb.2024.08.003_bib62","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41577-023-00848-y","article-title":"Tissue-specific macrophages: How they develop and choreograph tissue biology","volume":"23","author":"Mass","year":"2023","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib63","article-title":"The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers","volume":"171","author":"Mestiri","year":"2024","journal-title":"Biomedicine &\u00a0Pharmacotherapy"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib64","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annual Review of Immunology"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.08.003_bib65","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nature Reviews Immunology"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.003_bib66","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ccr.2011.11.003","article-title":"IL-10 elicits IFNgamma-dependent tumor immune surveillance","volume":"20","author":"Mumm","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib67","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annual Review of Physiology"},{"issue":"11","key":"10.1016\/bs.ircmb.2024.08.003_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049446","article-title":"Functionally suppressive CD8 T regulatory cells are increased in patients with multiple myeloma: A cause for immune impairment","volume":"7","author":"Muthu Raja","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.ircmb.2024.08.003_bib69","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood-2012-04-421826","article-title":"High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells","volume":"121","author":"Myklebust","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.003_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213813","article-title":"Comparative proteomic study reveals the enhanced immune response with the blockade of interleukin 10 with anti-IL-10 and anti-IL-10 receptor antibodies in human U937 cells","volume":"14","author":"Ni","year":"2019","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.08.003_bib71","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1080\/21645515.2020.1717185","article-title":"Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task","volume":"16","author":"Ni","year":"2020","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"11","key":"10.1016\/bs.ircmb.2024.08.003_bib72","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1080\/10428194.2017.1306643","article-title":"Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival","volume":"58","author":"Nielsen","year":"2017","journal-title":"Leukemia & Lymphoma"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.003_bib73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.33696\/haematology.4.055","article-title":"Analysis of updates in multiple myeloma treatment and management","volume":"4","author":"Nieto","year":"2023","journal-title":"Journal\u00a0of\u00a0Clinical Haematology"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.003_bib74","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","article-title":"IL-10 family cytokines IL-10 and IL-22: From basic science to clinical translation","volume":"50","author":"Ouyang","year":"2019","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.08.003_bib75","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm.2232","article-title":"Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF","volume":"16","author":"Quigley","year":"2010","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.08.003_bib76","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1182\/blood-2015-07-659490","article-title":"Myeloma escape from immunity: An \u201cinside\u201d job","volume":"126","author":"Rapoport","year":"2015","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib77","doi-asserted-by":"crossref","first-page":"1370854","DOI":"10.3389\/fonc.2024.1370854","article-title":"Targeted therapy for multiple myeloma: An overview on CD138-based strategies","volume":"14","author":"Riccardi","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.003_bib78","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00767.x","article-title":"PD-1 signaling in primary T cells","volume":"229","author":"Riley","year":"2009","journal-title":"Immunological Reviews"},{"issue":"37","key":"10.1016\/bs.ircmb.2024.08.003_bib79","doi-asserted-by":"crossref","first-page":"59029","DOI":"10.18632\/oncotarget.10665","article-title":"A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis","volume":"7","author":"Rios-Tamayo","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.003_bib80","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2016-08-731885","article-title":"Targeting the PD-1\/PD-L1 axis in multiple myeloma: A dream or a reality?","volume":"129","author":"Rosenblatt","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.08.003_bib81","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1038\/leu.2014.137","article-title":"High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: Results from a French multicenter clinical trial","volume":"28","author":"Rossille","year":"2014","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.003_bib82","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ccell.2014.09.006","article-title":"Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells","volume":"26","author":"Ruffell","year":"2014","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.003_bib83","doi-asserted-by":"crossref","first-page":"34","DOI":"10.37796\/2211-8039.1405","article-title":"Red cell distribution width, neutrophil lymphocyte ratio and interleukin 10 are good prognostic markers in multiple myeloma","volume":"13","author":"Seyam","year":"2023","journal-title":"Biomedicine (Taipei)"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.003_bib84","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41375-020-0734-z","article-title":"B-cell maturation antigen (BCMA) in multiple myeloma: Rationale for targeting and current therapeutic approaches","volume":"34","author":"Shah","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib85","doi-asserted-by":"crossref","first-page":"m3176","DOI":"10.1136\/bmj.m3176","article-title":"Emerging immunotherapies in multiple myeloma","volume":"370","author":"Shah","year":"2020","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.08.003_bib86","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/10428191003699563","article-title":"Dysregulation in T helper 1\/T helper 2 cytokine ratios in patients with multiple myeloma","volume":"51","author":"Sharma","year":"2010","journal-title":"Leukemia & Lymphoma"},{"issue":"11","key":"10.1016\/bs.ircmb.2024.08.003_bib87","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1158\/1078-0432.CCR-07-4153","article-title":"Involvement of hepcidin in the anemia of multiple myeloma","volume":"14","author":"Sharma","year":"2008","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.003_bib88","first-page":"27","article-title":"Prognostic value of IL-10 and its relationship with disease stage in Iranian patients with multiple myeloma","volume":"19","author":"Shekarriz","year":"2018","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.003_bib89","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2023.12.015","article-title":"IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction","volume":"80","author":"Shiri","year":"2024","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.003_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030601","article-title":"Immunotherapy in multiple myeloma","volume":"9","author":"Soekojo","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.003_bib91","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMoa2312054","article-title":"Daratumumab, bortezomib, lenalidomide, and dexamethasone for multiple myeloma","volume":"390","author":"Sonneveld","year":"2024","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib92","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.imlet.2023.06.005","article-title":"Targeting plasma cells in systemic autoimmune rheumatic diseases\u2014Promises and pitfalls","volume":"260","author":"Steinmetz","year":"2023","journal-title":"Immunol. Lett."},{"issue":"8","key":"10.1016\/bs.ircmb.2024.08.003_bib93","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-14-3016","article-title":"IL10 and PD-1 cooperate to limit the activity of tumor-specific CD8+ T cells","volume":"75","author":"Sun","year":"2015","journal-title":"Cancer Research"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.08.003_bib94","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"issue":"7693","key":"10.1016\/bs.ircmb.2024.08.003_bib95","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature25492","article-title":"TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.003_bib96","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41408-021-00432-4","article-title":"Management of patients with multiple myeloma beyond the clinical-trial setting: Understanding the balance between efficacy, safety and tolerability, and quality of life","volume":"11","author":"Terpos","year":"2021","journal-title":"Blood Cancer Journal"},{"issue":"9","key":"10.1016\/bs.ircmb.2024.08.003_bib97","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.V93.9.3064.409k07_3064_3073","article-title":"Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma","volume":"93","author":"Vacca","year":"1999","journal-title":"Blood"},{"issue":"38","key":"10.1016\/bs.ircmb.2024.08.003_bib98","doi-asserted-by":"crossref","first-page":"41228","DOI":"10.18632\/oncotarget.5682","article-title":"Serum levels of soluble programmed death ligand 1 predict treatment response and progression free survival in multiple myeloma","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.003_bib99","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/bjc.2016.11","article-title":"High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma","volume":"114","author":"Wang","year":"2016","journal-title":"British Journal of Cancer"},{"issue":"7446","key":"10.1016\/bs.ircmb.2024.08.003_bib100","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.003_bib101","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ncrna.2024.01.015","article-title":"Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance","volume":"9","author":"Xu","year":"2024","journal-title":"Non-coding RNA\u00a0Research"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.08.003_bib102","article-title":"Macrophages facilitate tumor cell PD-L1 expression via an IL-1beta-centered loop to attenuate immune checkpoint blockade","volume":"4","author":"Xu","year":"2023","journal-title":"MedComm (2020)"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.08.003_bib103","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.4049\/jimmunol.149.7.2378","article-title":"IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells","volume":"149","author":"Yssel","year":"1992","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.003_bib104","first-page":"94","article-title":"Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma","volume":"12","author":"Yu","year":"2019","journal-title":"Journal of\u00a0Hematology\u00a0&\u00a0Oncology"},{"issue":"11","key":"10.1016\/bs.ircmb.2024.08.003_bib105","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1631\/jzus.B2200277","article-title":"High levels of serum IL-10 indicate disease progression, extramedullary involvement, and poor prognosis in multiple myeloma","volume":"23","author":"Yue","year":"2022","journal-title":"Journal of Zhejiang University Science B"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.003_bib106","first-page":"338","article-title":"Shared genetic and epigenetic changes link aging and cancer","volume":"32","author":"Zabransky","year":"2022","journal-title":"Trends\u00a0in\u00a0Cell Biology"},{"issue":"Pt A","key":"10.1016\/bs.ircmb.2024.08.003_bib107","article-title":"Interleukin-10 increases macrophage-mediated chemotherapy resistance via FABP5 signaling in multiple myeloma","volume":"124","author":"Zhang","year":"2023","journal-title":"International Immunopharmacology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.08.003_bib108","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.V74.1.11.11","article-title":"Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma","volume":"74","author":"Zhang","year":"1989","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2024.08.003_bib109","first-page":"7569809","article-title":"The genetic polymorphisms of NLRP3 inflammasome associated with T helper cells in patients with multiple myeloma","volume":"2018","author":"Zhao","year":"2018","journal-title":"Journal of\u00a0Immunology Research"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.08.003_bib110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nature Reviews Immunology"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.08.003_bib111","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2326","article-title":"Inhibitory B7-family molecules in the tumour microenvironment","volume":"8","author":"Zou","year":"2008","journal-title":"Nature Reviews Immunology"}],"container-title":["International Review of Cell and Molecular Biology","Circulating biomarkers for diagnosis, prognosis and treatment response prediction in cancer \u2013 Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644824001205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644824001205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T21:52:02Z","timestamp":1750888322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1937644824001205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443345296"],"references-count":111,"URL":"https:\/\/doi.org\/10.1016\/bs.ircmb.2024.08.003","relation":{},"ISSN":["1937-6448"],"issn-type":[{"value":"1937-6448","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}